According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal ...

The research, published in JAMA, suggests that active monitoring could be a viable alternative to surgery and radiation for low-risk patients with ductal carcinoma in situ (DCIS), known as stage zero ...

According to two new studies presented Thursday at the San Antonio Breast Cancer Symposium, active monitoring of ductal ...

The first study comparing surgery to active monitoring as treatment for ductal carcinoma in situ (DCIS) finds women who carefully monitor the precancerous cells are no more likely to develop breast ...

For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) ...

Researchers examined pooled data from two clinical trials that enrolled patients with low- or intermediate-grade ductal ...

Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...

An analysis of phase 3 trials found tamoxifen significantly reduced 15-year ipsilateral breast recurrence in patients with ...

Women report having similar quality of life whether randomized to active monitoring or surgery for low-risk ductal carcinoma ...

A study based at Duke may change the standard of care for ductal carcinoma in situ (DCIS), known as stage zero breast cancer. A study based at Duke may change the standard of care for ductal carcinoma ...

Two recent studies explore options for early-stage breast cancer patients to reduce surgery. One suggests active monitoring ...

Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, ...